nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Achievements and future of chemotherapy
|
Verweij, J |
|
2000 |
36 |
12 |
p. 1479-1487 9 p. |
artikel |
2 |
Analysis of the fragile histidine triad (FHIT) gene in lobular breast cancer
|
Huiping, C |
|
2000 |
36 |
12 |
p. 1552-1557 6 p. |
artikel |
3 |
Assessment of percutaneous fine needle aspiration cytology as a technique to provide diagnostic and prognostic information in neuroblastoma
|
Thiesse, P |
|
2000 |
36 |
12 |
p. 1544-1551 8 p. |
artikel |
4 |
Challenges and pitfalls of mass-screening in the European Union
|
Coebergh, J.W.W. |
|
2000 |
36 |
12 |
p. 1469-1472 4 p. |
artikel |
5 |
Combination raltitrexed (Tomudex®)–oxaliplatin: a step forward in the struggle against mesothelioma? The Institut Gustave Roussy experience with chemotherapy and chemo-immunotherapy in mesothelioma
|
Fizazi, K |
|
2000 |
36 |
12 |
p. 1514-1521 8 p. |
artikel |
6 |
Economics and health-related quality of life in antiemetic therapy: recommendations for trial design
|
Uyl-de Groot, C.A |
|
2000 |
36 |
12 |
p. 1522-1535 14 p. |
artikel |
7 |
Efficacy and toxicity profile of oral topotecan in a panel of human tumour xenografts
|
De Cesare, M |
|
2000 |
36 |
12 |
p. 1558-1564 7 p. |
artikel |
8 |
Evaluation of the efficacy of potential antineoplastic drugs on tumour metastasis by a computer-assisted image analysis
|
Lentini, A |
|
2000 |
36 |
12 |
p. 1572-1577 6 p. |
artikel |
9 |
Forewarned is forearmed — benefits of preparatory information on video cassette for patients receiving chemotherapy or radiotherapy — a randomised controlled trial
|
Thomas, R. |
|
2000 |
36 |
12 |
p. 1536-1543 8 p. |
artikel |
10 |
Human papilloma virus status and chromosomal imbalances in primary cervical carcinomas and tumour cell lines
|
|
|
2000 |
36 |
12 |
p. 1587- 1 p. |
artikel |
11 |
Identification and interpretation of clinical and quality of life prognostic factors for survival and response to treatment in first-line chemotherapy in advanced breast cancer
|
Kramer, J.A |
|
2000 |
36 |
12 |
p. 1498-1506 9 p. |
artikel |
12 |
Influence of schedule of administration on methotrexate penetration in brain tumours
|
Dukic, S.F |
|
2000 |
36 |
12 |
p. 1578-1584 7 p. |
artikel |
13 |
Meta-analysis of studies on breast cancer risk and diet
|
|
|
2000 |
36 |
12 |
p. 1588- 1 p. |
artikel |
14 |
Modulation of drug resistance by α-tubulin in paclitaxel-resistant human lung cancer cell lines
|
Han, E. Kyu-Ho |
|
2000 |
36 |
12 |
p. 1565-1571 7 p. |
artikel |
15 |
Randomised trial of paclitaxel versus doxorubicin as first-line chemotherapy for advanced breast cancer: quality of life evaluation using the EORTC QLQ-C30 and the Rotterdam Symptom Checklist
|
Kramer, J.A |
|
2000 |
36 |
12 |
p. 1488-1497 10 p. |
artikel |
16 |
Recommendations on cancer screening in the European Union
|
|
|
2000 |
36 |
12 |
p. 1473-1478 6 p. |
artikel |
17 |
Refined deletion mapping in sporadic breast cancer at chromosomal region 8p12-p21 and association with clinicopathological parameters
|
Seitz, S. |
|
2000 |
36 |
12 |
p. 1507-1513 7 p. |
artikel |
18 |
Re: Tamoxifen for the prevention of breast cancer. Eur J Cancer 36 2000, 142–150. Relationship of trial design to value of data for patient?
|
Thornton, H. |
|
2000 |
36 |
12 |
p. 1585-1586 2 p. |
artikel |